Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 43, 2013 - Issue 6
492
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis of Some Novel Pyrimidinedione and Pyrimidinetrione Derivatives by a Greener Method: Study of Their Antimicrobial Activity and Photophysical Properties

, , &
Pages 865-876 | Received 18 May 2011, Published online: 21 Dec 2012
 

Abstract

A series of novel pyrimidinedione- and pyrimidinetriones-based compounds were synthesized by different techniques such as with conventional Knoevenagel condensation alone, with a Rhizopus oryzae lipase biocatalyst, and with a deep eutectic solvent (DES). The yield was found to be maximum by using lipase and DES. Reuse of the lipase and DES was possible up to four consecutive cycles. These methods are mild, highly efficient, and amenable to scaleup. The products were found to exhibit appreciable in vitro antibacterial activity against Echerichia coli, Pseudomonas neumoniae, and Micrococcus and in vitro antifungal activity against Aspergillus niger and Candida albicans. All the compounds exhibited appreciable in vitro activity against the tested strains. The photophysical properties and thermal stability of the products were also investigated.

GRAPHICAL ABSTRACT

Notes

a By using conventional catalyst, reactions were carried out at reflux temperature.

b By using lipase as a biocatalyst, reactions were carried out at 40–45 °C.

c By using deep eutectic solvent, reactions were carried out at 40–45 °C.

All compounds were confirmed by FTIR, 1NMR, 13C NMR, mass analysis.

d = Isolated Yield.

MIC: Minimal inhibitory concentration values.

Standard: bacterial strain: streptomycin 125 µg/mL, fungal strains: fluconazole 125 µg/mL.

Solvent used: DMSO (Dimethylsulphoxide).

a Bacterial strain: E. coli NCIMB 8110, Micrococcus, Pseudomonas neumoniae.

b Fungal Strain: Candida albicans; Aspergillus niger.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.